Monitoring blood sugar levels in people with and without prediabetes
Observation and Identification of Glycemic Metrics and Patterns in People With and Without Prediabetes (PREMAP)
This study is testing how blood sugar levels differ between people with prediabetes and those without to help improve diabetes management in the future.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Abbott Diabetes Care Industry-sponsored |
| Locations | 1 site (Bend, Oregon) |
| Trial ID | NCT06921902 on ClinicalTrials.gov |
What this trial studies
This observational study uses the FreeStyle Libre 3 Continuous Glucose Monitoring System to evaluate the glycemic profiles of individuals diagnosed with prediabetes compared to those without such a diagnosis. It aims to enroll up to 2000 participants across 20 sites, with approximately half of the subjects having a prediabetes diagnosis. The study is non-randomized and poses a non-significant risk to participants, focusing on understanding glycemic patterns to inform future diabetes management strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are willing to provide informed consent and do not have a current diabetes diagnosis.
Not a fit: Patients with a diagnosis of type 1 diabetes, type 2 diabetes, or those currently on diabetes treatment will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into glycemic patterns that may help in the early detection and prevention of diabetes.
How similar studies have performed: Other studies utilizing continuous glucose monitoring have shown promise in understanding glycemic control, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject must be at least 18 years of age. * Subject must be willing and able to provide written signed and dated informed consent. Exclusion Criteria: * Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes. * Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment. * Subject is known to be pregnant at the time of enrollment. * Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin. * Subject is currently on any form of treatment indicated for the treatment of diabetes. * Subject is currently on any form of medication indicated for weight loss.
Where this trial is running
Bend, Oregon
- Diabetes and Obesity Care — Bend, Oregon, United States (Recruiting)
Study contacts
- Study coordinator: MOHAMED NADA, PhD
- Email: adc.clinical@abbott.com
- Phone: 5107495416
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.